Researchers could soon formulate a blood test that helps with early Alzheimer's diagnosis


Researchers have discovered 10 proteins in blood that might be able to predict Alzheimer's, and even form the basis for a blood test that could diagnose the disease before symptoms start.
In a study published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, researchers from King's College London were able to accurately predict Alzheimer's disease nearly nine times out of 10. More than 1,100 people participated in the study, and researchers found that 16 of the 26 proteins associated with Alzheimer's were closely tied to the brain shrinkage found in a person with mild cognitive impairment and Alzheimer's. Researchers ran more tests, and found that 10 proteins could be markers that mild cognitive impairment will develop into Alzheimer's.
Looking at these protein levels, researchers were able to correctly predict Alzheimer's disease in 87 percent of the cases. The goal now is to use the information gleaned from the study to create a blood test that could diagnose Alzheimer's early, when medications should have the biggest effect, and treat it before symptoms even begin.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"You take a drug, and in effect you would have the clinical symptoms prevented — even if the disease has already started in your brain," Oxford's Simon Loveston, the study's senior author, told CBS News. Such a breakthrough would be huge: 5.1 million Americans have Alzheimer's, and the rates are expected to triple by 2050. Every year, an estimated $215 billion is spent in the U.S. on Alzheimer's disease and other forms of dementia.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Should you add your child to your credit card?
The Explainer You can make them an authorized user on your account in order to help them build credit
-
Cracker Barrel crackup: How the culture wars are upending corporate branding
In the Spotlight Is it 'woke' to leave nostalgia behind?
-
'It's hard to discern what it actually means'
Instant Opinion Opinion, comment and editorials of the day
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC